Table 4 SJIA patient (flare and quiescent plasma samples) characteristics—patient demographics
Parameters | SJIA F n = 25 (training) | SJIA Q n = 14 (training) | SJIA F n = 41 (bootstrapping testing) | SJIA Q n = 11 (bootstrapping testing) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Obs. | Median | SD | Range | Obs. | Median | SD | Range | Obs. | Median | SD | Range | Obs. | Median | SD | Range | |
Age (year) | 24 | 9.00 | 4.04 | 2–16 | 14 | 10.00 | 4.08 | 2–16 | 22 | 9.00 | 4.17 | 2–16 | 9 | 10.00 | 5.34 | 3–19 |
Gender (male%) | 25 | 60% | 9 | 43% | 19 | 58% | 8 | 38% | ||||||||
WBC (103/ul) | 25 | 13.90 | 5.75 | 8.1–32.6 | 14 | 7.10 | 2.21 | 4.2–11.6 | 35 | 14.00 | 9.00 | 4.8–38.5 | 11 | 6.80 | 3.20 | 4.2–12.6 |
ESR (mm/h) | 24 | 96.50 | 36.36 | 10–143 | 14 | 10.50 | 6.43 | 2–24 | 31 | 80.00 | 34.38 | 6–131 | 8 | 9.00 | 6.45 | 7–25 |
CRP (mg/dL) | 16 | 7.40 | 8.50 | 0.2–26.6 | 3 | 0.40 | 0.40 | 0.4–1.10 | 14 | 7.25 | 8.02 | 0.4–26.6 | 4 | 0.40 | 0.39 | 0.2–1.1 |
PLT (103/ul) | 25 | 500.00 | 188.37 | 172–952 | 14 | 299.00 | 64.52 | 207–410 | 35 | 497.00 | 161.14 | 259–1085 | 11 | 293.00 | 50.07 | 216–355 |
NSAID (subjects%) | 25 | 96% | 8 | 57% | 35 | 86% | 11 | 73% | ||||||||
PO.PRED (subjects%) | 25 | 48% | 8 | 29% | 35 | 66% | 11 | 18% | ||||||||
MTX (subjects%) | 25 | 16% | 8 | 36% | 35 | 40% | 11 | 18% | ||||||||
TNF (subjects%) | 25 | 16% | 8 | 43% | 35 | 37% | 11 | 64% | ||||||||
IL.1.RA (subjects%) | 25 | 4% | 8 | 7% | 35 | 6% | 11 | 9% | ||||||||